Address
Sofinnova Ventures Inc
2800 Sand Hill Road
Suite 150
Menlo Park, CA 94025
United States
Phone
Website
Industry
Recent investment activity
KANDO id: 2247
Funds managed
| Fund | Type | Vintage | Currency | Committed capital | IRR |
|---|---|---|---|---|---|
| Sofinnova Industrial Biotech | Venture | 2017 | EUR | 106,000,000 | |
| Sofinnova Venture Partners X LP | Venture | 2016 | USD | 650,000,000 | |
| Sofinnova Venture Partners IX LP | Venture | 2014 | USD | 500,000,000 | |
| Sofinnova Venture Partners VIII LP | Venture | 2011 | USD | 440,000,000 | |
| Sofinnova Venture Partners VII LP | Venture | 2006 | USD | 375,000,000 | 17.11 % |
| Sofinnova Venture Partners VI | Venture | 2003 | USD | 220,000,000 | -6.03 % |
| Sofinnova Venture Partners V | Venture | 2000 | USD | 210,000,000 |
Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 1 - 25 of 48| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
| Aerie Pharmaceuticals Inc | Series B | |||||
| Alvine Pharmaceuticals Inc | An innovative biopharmaceutical company developing biologics to target autoimmune/ inflammatory diseases. | N/A | ||||
| Anthera Pharmaceuticals Inc | N/A | |||||
| Ascenta Therapeutics Inc | A privately-held, clinical stage biopharmaceutical company dedicated to the discovery and development of new medicines to treat cancer. | N/A | ||||
| Auris Medical | Series C | |||||
|
BeamReach Networks Inc | N/A | ||||
| Calient Technologies Inc | Optical switches for enhanced data center performance. | Venture | ||||
| Catalyst Biosciences Inc | Developer of catalytic biopharmaceutical products based on engineered human proteases. | Series C | ||||
| Catalyst Biosciences Inc | Developer of catalytic biopharmaceutical products based on engineered human proteases. | Series B | ||||
| Catalyst Biosciences Inc | Developer of catalytic biopharmaceutical products based on engineered human proteases. | Series A | ||||
| Cebix Inc | Series B | |||||
| Cebix Inc | N/A | |||||
| Cellective Therapeutics Inc | N/A | |||||
| Cerenis Therapeutics SA | Series C | |||||
| CoAxia Inc | A medical device company that researches therapy and treatment solutions for cerebral ischemia | Series D | ||||
| Contextream Inc | ConteXtream is a privately held software company. | Series A | ||||
| Cortina Systems Inc | N/A | |||||
| CoTherix Inc | N/A | |||||
| DiObex Inc | Biotechnology company that develops novel products for the treatment of metabolic disorders. | N/A | ||||
| Durata Therapeutics Inc | Durata Therapeutics is a clinical development stage biopharmaceutical company. | N/A | ||||
| Envivio Inc | Developer of MPEG-4 solutions for broadcasters, enterprises, and service providers. | N/A | ||||
| Flexion Therapeutics Inc | Discovers and develops innovative therapeutics for musculoskeletal disorders | N/A | ||||
| Histogenics Corp | Histogenics Corporation expertise and focus is on repairing articular cartilage damage. | Series A | ||||
| Hyperion Therapeutics Inc | Hyperion Therapeutics is a privately held specialty pharmaceutical company focused on the development of therapies that address critical unmet needs i | N/A | ||||
| INSIDE Secure SA | N/A |
Team
| Employee | Position | ||
|---|---|---|---|
| Alain Azan (founder) | |||
| Nathalie Auber | |||
| James I Healy | |||
| David Kabakoff | |||
| Anand Mehra | |||
| Michael Powell | |||
| Bill Ringo | |||
| Goro Takeda | |||
| Brian Wilcove | |||
| Alfred Yue | |||
| Lars Ekman | |||
| Garheng Kong |
Former team members
| Employee | Company | Position | ||
|---|---|---|---|---|
| Eric Buatois | Benhamou Global Ventures LLC |